Join
Live feed
·
INSIDERFilingvia Quantisnow
CorMedix Inc. logo

Director Kaplan Myron bought $275,500 worth of shares (25,000 units at $11.02), increasing direct ownership by 14% to 201,034 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CRMD· CorMedix Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRMD (CorMedix Inc.) and more on Quantisnow.